vs

Side-by-side financial comparison of CareTrust REIT, Inc. (CTRE) and JBG SMITH Properties (JBGS). Click either name above to swap in a different company.

CareTrust REIT, Inc. is the larger business by last-quarter revenue ($134.9M vs $127.6M, roughly 1.1× JBG SMITH Properties). CareTrust REIT, Inc. runs the higher net margin — 82.5% vs -35.7%, a 118.2% gap on every dollar of revenue. On growth, CareTrust REIT, Inc. posted the faster year-over-year revenue change (55.1% vs -2.5%). Over the past eight quarters, CareTrust REIT, Inc.'s revenue compounded faster (46.2% CAGR vs -6.3%).

Target Healthcare REIT is a British property investment company which invests in healthcare properties and holds a large portfolio of care homes. It is structured as a real estate investment trust (REIT) and is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

JBG SMITH Properties is a publicly traded real estate investment trust based in Bethesda, Maryland.

CTRE vs JBGS — Head-to-Head

Bigger by revenue
CTRE
CTRE
1.1× larger
CTRE
$134.9M
$127.6M
JBGS
Growing faster (revenue YoY)
CTRE
CTRE
+57.6% gap
CTRE
55.1%
-2.5%
JBGS
Higher net margin
CTRE
CTRE
118.2% more per $
CTRE
82.5%
-35.7%
JBGS
Faster 2-yr revenue CAGR
CTRE
CTRE
Annualised
CTRE
46.2%
-6.3%
JBGS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTRE
CTRE
JBGS
JBGS
Revenue
$134.9M
$127.6M
Net Profit
$111.3M
$-45.5M
Gross Margin
Operating Margin
-47.5%
Net Margin
82.5%
-35.7%
Revenue YoY
55.1%
-2.5%
Net Profit YoY
113.5%
24.0%
EPS (diluted)
$0.52
$-0.76

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTRE
CTRE
JBGS
JBGS
Q4 25
$134.9M
$127.6M
Q3 25
$132.4M
$123.9M
Q2 25
$112.5M
$126.5M
Q1 25
$96.6M
$120.7M
Q4 24
$86.9M
$130.8M
Q3 24
$77.4M
$136.0M
Q2 24
$68.9M
$135.3M
Q1 24
$63.1M
$145.2M
Net Profit
CTRE
CTRE
JBGS
JBGS
Q4 25
$111.3M
$-45.5M
Q3 25
$74.9M
$-28.6M
Q2 25
$68.5M
$-19.2M
Q1 25
$65.8M
$-45.7M
Q4 24
$52.1M
$-59.9M
Q3 24
$33.4M
$-27.0M
Q2 24
$10.8M
$-24.4M
Q1 24
$28.7M
$-32.3M
Operating Margin
CTRE
CTRE
JBGS
JBGS
Q4 25
-47.5%
Q3 25
58.1%
-27.5%
Q2 25
61.3%
-18.4%
Q1 25
-44.7%
Q4 24
-53.6%
Q3 24
43.0%
-22.4%
Q2 24
15.1%
-24.3%
Q1 24
-30.1%
Net Margin
CTRE
CTRE
JBGS
JBGS
Q4 25
82.5%
-35.7%
Q3 25
56.6%
-23.1%
Q2 25
60.9%
-15.2%
Q1 25
68.1%
-37.9%
Q4 24
60.0%
-45.8%
Q3 24
43.2%
-19.8%
Q2 24
15.6%
-18.0%
Q1 24
45.6%
-22.2%
EPS (diluted)
CTRE
CTRE
JBGS
JBGS
Q4 25
$0.52
$-0.76
Q3 25
$0.35
$-0.48
Q2 25
$0.35
$-0.29
Q1 25
$0.35
$-0.56
Q4 24
$0.30
$-0.70
Q3 24
$0.21
$-0.32
Q2 24
$0.07
$-0.27
Q1 24
$0.22
$-0.36

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTRE
CTRE
JBGS
JBGS
Cash + ST InvestmentsLiquidity on hand
$198.0M
$75.3M
Total DebtLower is stronger
$894.2M
Stockholders' EquityBook value
$4.0B
$1.2B
Total Assets
$5.1B
$4.4B
Debt / EquityLower = less leverage
0.22×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTRE
CTRE
JBGS
JBGS
Q4 25
$198.0M
$75.3M
Q3 25
$712.5M
$64.4M
Q2 25
$306.1M
$61.4M
Q1 25
$26.5M
$81.3M
Q4 24
$213.8M
$145.8M
Q3 24
$377.1M
$137.0M
Q2 24
$495.1M
$163.5M
Q1 24
$451.2M
$220.5M
Total Debt
CTRE
CTRE
JBGS
JBGS
Q4 25
$894.2M
Q3 25
$893.8M
Q2 25
$1.2B
Q1 25
$822.1M
Q4 24
$396.9M
Q3 24
$396.7M
Q2 24
$671.1M
Q1 24
$595.9M
Stockholders' Equity
CTRE
CTRE
JBGS
JBGS
Q4 25
$4.0B
$1.2B
Q3 25
$4.0B
$1.2B
Q2 25
$3.3B
$1.3B
Q1 25
$2.9B
$1.6B
Q4 24
$2.9B
$1.8B
Q3 24
$2.4B
$1.9B
Q2 24
$1.9B
$2.0B
Q1 24
$1.7B
$2.1B
Total Assets
CTRE
CTRE
JBGS
JBGS
Q4 25
$5.1B
$4.4B
Q3 25
$5.1B
$4.4B
Q2 25
$4.7B
$4.5B
Q1 25
$3.9B
$4.7B
Q4 24
$3.4B
$5.0B
Q3 24
$2.9B
$5.2B
Q2 24
$2.7B
$5.3B
Q1 24
$2.3B
$5.4B
Debt / Equity
CTRE
CTRE
JBGS
JBGS
Q4 25
0.22×
Q3 25
0.22×
Q2 25
0.35×
Q1 25
0.28×
Q4 24
0.14×
Q3 24
0.16×
Q2 24
0.35×
Q1 24
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTRE
CTRE
JBGS
JBGS
Operating Cash FlowLast quarter
$394.0M
$73.3M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.54×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTRE
CTRE
JBGS
JBGS
Q4 25
$394.0M
$73.3M
Q3 25
$100.9M
$8.9M
Q2 25
$100.8M
$18.8M
Q1 25
$71.4M
$12.9M
Q4 24
$244.3M
$129.4M
Q3 24
$67.2M
$26.4M
Q2 24
$53.0M
$23.8M
Q1 24
$48.8M
$37.0M
Cash Conversion
CTRE
CTRE
JBGS
JBGS
Q4 25
3.54×
Q3 25
1.35×
Q2 25
1.47×
Q1 25
1.08×
Q4 24
4.68×
Q3 24
2.01×
Q2 24
4.92×
Q1 24
1.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons